ArticleJACC. CardioOncology2023

Cardiac Toxicity of Alectinib in Patients With ALK+ Lung Cancer: Outcomes of Cardio-Oncology Follow-Up.

Melinda A Pruis et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.